Latest news with #ScrippsHealth
Business Upturn
19-06-2025
- Business
- Business Upturn
Rpharmy Serves as Platinum Sponsor of North Carolina Association of Pharmacists Annual Convention
AUSTIN, Texas, June 19, 2025 (GLOBE NEWSWIRE) — Rpharmy , a leading provider of medical formulary management and hazardous drug safety information software solutions, today announced the company is a Platinum Sponsor of the North Carolina Association of Pharmacists Annual Convention to be held June 23-25, 2025, in Asheville, N.C. Rpharmy client and Rhazdrugs user, Erica Bane, Pharm.D. BCPS, Medication Safety Officer at Scripps Health, will also host a Lunch and Learn event on June 24th at 12 pm, sharing best practices for protecting healthcare workers from exposure to hazardous drugs and USP <800> compliance. The Rpharmy team will also be hosting product demos of Formweb, the web-based medication safety resource platform, and Rhazdrugs, a hazardous drug safety and USP <800> compliance solution. Find us during the Exhibitor Expo Lunch and Posters on June 23 from 11:30 am – 2:30 pm and in Booth #11 on June 23rd, 8:00 am – 5:00 pm, and June 24th, 8:00 am – 5:00 pm during the rest of the conference. 'We're proud to be a platinum sponsor of the NCAP Annual Conference, an essential gathering for pharmacists and healthcare leaders, especially at such a pivotal time in the industry,' said Laura Paxton, founder and CEO of Rpharmy. 'Attendees will have a unique opportunity to hear Erica Bane from Scripps Health share how she simplified and improved hazardous drug safety using our Rhazdrugs solution. Her story is a powerful example of how healthcare systems can work across departments to better protect their teams from the risks of hazardous drug exposure. We also look forward to reconnecting with longtime colleagues and making new connections at NCAP 2025.' Every year, more than 8 million healthcare workers are exposed to hazardous drugs, according to the Centers for Disease Control and Prevention (CDC), which can result in serious health risks like cancer and reproductive harm. Rpharmy's Rhazdrugs is a powerful, electronic healthcare record-integrated solution built to help healthcare organizations proactively protect their staff, simplify USP <800> compliance, and reduce the time and cost of managing hazardous drug information. The 25th NCAP Annual Conference will be held at the historical Crowne Plaza Resort in Asheville, N.C., where pharmacy leaders and innovators will spend three days sharing insights, education and connections. Learn more at . About Rpharmy For more than 30 years, Rpharmy has been solving problems related to medication safety and patient care. We develop and provide technology focused on medical formulary, hazardous drug handling, and compliance with HFAP, NIOSH and The Joint Commission. Our primary goal is to ensure the safety of all patients and healthcare workers through easy access to critical medication safety information. For more information, visit Media Contact: Carrie Ward, PR for Rpharmy, 832-407-5347, [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
07-05-2025
- Health
- Yahoo
Scripps Health announces extension of contract with Anthem Blue Cross
SAN DIEGO (FOX 5/KUSI) — People insured under Anthem Blue Cross will once again have in-network access to Scripps Health's hospitals and medical providers after the two entities agreed to extend contracts. In an announcement by Scripps on Tuesday, the health system said they have agreed to extend in-network contracts until Sept. 30, 2026, effective immediately. San Diego-based Aya Healthcare announces death of founder Alan Braynin The move comes after several months of failed negotiations between Scripps and the insurance company, following the expiration of their previous contract on Dec. 31. The two entities did not reach an agreement by midnight on Jan. 1, thus putting Scripps Health's hospitals, outpatient clinics and physicians out-of-network for approximately 125,000 patients in California who were covered by Anthem Blue Cross. In its update Tuesday, Scripps announced it will work with the insurance company to negotiate a 'new, sustainable, long-term agreement that ensures patients can access Scripps through an Anthem network.' 'We recognize the past four months have been difficult for our Anthem Blue Cross patients and our physicians, and we have been doing all we can to reach this extension term, and, ultimately, a longer-term agreement,' Scripps stated. 'We are pleased Scripps Health has rejoined our local network of care providers in San Diego and we look forward to continuing our partnership,' said Beth Andersen, President Anthem Commercial Health Plans in California. 'Our members and employer customers remained our number one priority as we worked hard and in good faith to find common ground and reach a new agreement with Scripps.' The terms of the contract extension are 'effective immediately,' the health system said, again allowing Anthem members in-network access to Scripps' health services. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. For the latest news, weather, sports, and streaming video, head to FOX 5 San Diego & KUSI News.
Yahoo
02-04-2025
- Business
- Yahoo
Scripps Health named among Fortune's ‘100 Best Companies to Work For'
(Above: Nexstar Media Wire video on how many hours a week people in other countries work) SAN DIEGO (FOX 5/KUSI) — A San Diego employer has been named in Fortune's list of the 100 Best Companies to Work For, which was released Wednesday. Scripps Health was named one of the top employers in the country by the business magazine for the 17th time. This year, it was the only company in San Diego County to make the list. It came in at No. 97 out of 100 selected based on 1.3 million confidential survey responses from employees. The responses were only considered if they came from people who work at companies that earned the Great Place To Work certification. La Jolla cityhood effort reaches milestone with more signatures To qualify for a place on the list, companies were assessed on how well they enhance the employee experience across job levels, business units, races, ages, genders, disability status, and others. In a news release Wednesday announcing the coveted distinction, Scripps said it has helped improve workplace safety, supported workers in their personal and professional lives, and offered them professional development opportunities. 'Our people are our greatest strength, and we're proud to continually invest highly in their development, well-being and success,' said Chris Van Gorder, Scripps Health president and CEO. Scripps Health was founded in 1924 by Ellen Browning Scripps, a philanthropist whose name extends beyond health care. She helped found the Scripps Institution of Oceanography, La Jolla Woman's Club and The Bishop's School. Additionally, a City of San Diego park is named in her honor at 1100 Coast Blvd. in La Jolla. Scripps currently consists of five acute-care hospital campuses, home health care services, 30 outpatient centers and clinics and hundreds of affiliated physician offices. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
03-03-2025
- Business
- Yahoo
Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday?
Aclarion, Inc. (NASDAQ:ACON) shares are trading higher premarket on Monday after the company disclosed a commercial partnership with in San Diego, CA. This agreement will introduce Nociscan to Southern California and to the top spine specialists at Scripps Green and Scripps Health. Notably, Scripps Health is a nonprofit healthcare system that operates five hospitals and 19 outpatient facilities, serving half a million patients annually with the support of 2,600 affiliated physicians. Ryan Bond, Chief Strategy Officer of Aclarion. 'We are pleased to bring Nociscan to Scripps Health and the millions of people throughout Southern California. Dr. Eastlack and his colleagues will now be able to utilize Nociscan in clinic and within on-going research trials, both of which are vitally important to their mission of advancing spine care.' Last month, the company announced it secured funding for its CLARITY trial of its diagnostic tool, Nociscan. Also, Aclarion identified Northwestern Medicine as the first site for the pivotal CLARITY trial, which aims to showcase Nociscan's clinical and economic benefits in spine surgery. Price Action: ACON shares are up 84.8% at $6.19 premarket at the last check Monday. Read Next:Photo: One Photo via Shutterstock. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday? originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
03-03-2025
- Health
- Yahoo
Aclarion Announces First Commercial Agreement with Scripps Health
BROOMFIELD, Colo., March 03, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ('Aclarion' or the 'Company') (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today it has established a commercial agreement with Scripps Health in San Diego, CA. The agreement brings Nociscan to southern California and the leading spine physicians of Scripps Green and Scripps Health, the largest healthcare system in the San Diego area. 'Each year at Scripps, we evaluate a large, growing number of patients suffering from chronic low back pain,' said Robert Eastlack, MD, Orthopedic Surgeon, Scripps Health. 'I have a keen interest in advanced diagnostics and clinical decision support tools like Nociscan. Over the last few years, I have referred numerous patients to Beverly Hills for Nociscan. The additional information unique from Nociscan has been valuable to me and my patients. Having Nociscan available at Scripps Green will greatly expand access to my colleagues and our patients in important ways.' Scripps Health is a nonprofit health care system that includes five hospitals and 19 outpatient facilities and treats a half-million patients annually through 2,600 affiliated physicians. The system also includes clinical research and medical education programs. 'Dr. Eastlack is a leader within Scripps, as well as the San Diego Spine Foundation and the International Spine Study Group, having published over 100 peer-reviewed articles and contributing to nearly a dozen textbooks,' said Ryan Bond, Chief Strategy Officer of Aclarion. 'We are pleased to bring Nociscan to Scripps Health and the millions of people throughout Southern California. Dr. Eastlack and his colleagues will now be able to utilize Nociscan in clinic and within on-going research trials, both of which are vitally important to their mission of advancing spine care.' Chronic low back pain (cLBP) is a global healthcare problem with approximately 266 million people worldwide suffering from degenerative spine disease and low back pain. Aclarion's Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan objectively quantifies chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain. To find a Nociscan center, view our site map here. For more information on Nociscan, please email: info@ This press release is for informational purposes only and is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or to buy any securities or a solicitation of any proxy, consent, vote or approval with respect to any securities of Aclarion, Inc. No offer, sale, issuance or transfer of securities shall be made in any jurisdiction in which such offer, sale, issuance or transfer would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. About Aclarion, Inc. Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ('MRS'), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company's current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as 'anticipates,' 'believes' and 'expects' or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled 'Risk Factors' in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, as well as other disclosures contained in the Prospectus and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor Contacts: Kirin M. SmithPCG Advisory, Media Contacts: Jennie KimSPRIG Consultingjennie@ in to access your portfolio
